Physician profile
John C Wirth
NPI 1861456105
$2,721.17
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,683 · 2020: $277 · 2021: $81.97 · 2022: $205 · 2023: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,382.94 | 2019-2022 | |
| Lupin INC. | $196.11 | 2019-2020 | |
| Coopersurgical, INC. | $191.26 | 2019-2022 | |
| Avion Pharmaceuticals | $139.00 | 2019-2021 | |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Glaxosmithkline, LLC. | $114.58 | 2023 | |
| Myriad Women'S Health, INC. | $109.53 | 2023 | Myrisk |
| Pfizer INC. | $102.45 | 2023 | |
| Exeltis, USA INC. | $88.41 | 2019-2020 | |
| Hologic Sales and Service, LLC | $74.10 | 2020-2022 | |
| Allergan, INC. | $53.81 | 2019 | |
| Vertical Pharmaceuticals, LLC | $36.75 | 2019 | |
| Roche Diagnostics Corporation | $25.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.93 | 2019 | |
| Mayne Pharma Commercial LLC | $22.86 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.14 | 2019 | |
| Aspira Women'S Health INC | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.